Predictmedix Preps for Big Year Ahead, as Demand for its Contactless Screening Devices sees Ramp Up of Partnerships, M&A and Strategic Financing
AGORACOM Small Cap CEO Interviews - Podcast tekijän mukaan AGORACOM
Kategoriat:
Predictmedix is an Artificial Intelligence company that has developed fast, non-invasive, contactless screening devices that detect infectious diseases, impairment and even mental illness at any location where mass amounts of people gather, such as: Hospitals Stadiums Airports Malls Government Buildings Office Complexes These screeners are fully automated and intelligent, so they don’t need personnel to operate them. They determine the probability of a person being infected with illnesses such as COVID-19, so safety protocols can be initiated. Earlier this month, the AI firm penned a major strategic partnership with Juiceworks and Connectus Global to deploy its Safe Entry Stations nationwide. That news came during an increasingly busy time for $PMED, which has included: An LOI to acquire AI-powered tech firm Symp2Pass The engagement of investment banking firm Kingswood Capital Markets in preparation for NASDAQ listing Major partnerships Strategic financing developments You’re going to want to get comfy for this chat with Predictmedix COO & Director Rahul Kushwah:
